165 related articles for article (PubMed ID: 37897650)
1. Clinical characteristics, treatment, and management of pembrolizumab induced hemophagocytic lymphohistiocytosis.
Wang C; Sun W; Li Z; Wu T; Fang W
Invest New Drugs; 2023 Dec; 41(6):834-841. PubMed ID: 37897650
[TBL] [Abstract][Full Text] [Related]
2. Hemophagocytic lymphohistiocytosis with immunotherapy: brief review and case report.
Sadaat M; Jang S
J Immunother Cancer; 2018 Jun; 6(1):49. PubMed ID: 29871698
[TBL] [Abstract][Full Text] [Related]
3. Causes, clinical symptoms, and outcomes of infectious diseases associated with hemophagocytic lymphohistiocytosis in Taiwanese adults.
Tseng YT; Sheng WH; Lin BH; Lin CW; Wang JT; Chen YC; Chang SC
J Microbiol Immunol Infect; 2011 Jun; 44(3):191-7. PubMed ID: 21524613
[TBL] [Abstract][Full Text] [Related]
4. Hemophagocytic lymphohistiocytosis following pembrolizumab and bevacizumab combination therapy for cervical cancer: a case report and systematic review.
Zhai C; Jin X; You L; Yan N; Dong J; Qiao S; Zhong Y; Zheng Y; Pan H
BMC Geriatr; 2024 Jan; 24(1):32. PubMed ID: 38191289
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the clinical characteristics of lamotrigine-induced haemophagocytic lymphohistiocytosis.
Wang C; Fan Z; He Y; Fang W; Sun W; Li Z
J Clin Pharm Ther; 2022 Jun; 47(6):745-751. PubMed ID: 35023173
[TBL] [Abstract][Full Text] [Related]
6. [Hemophagocytic lymphohistiocytosis caused by hematogenous disseminated pulmonary tuberculosis: A case report].
Li QY; Liang Y; Dai NN; Wang YX; Zhu BT; Wu R; Zhu H; Sun YC
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 54(6):1219-1223. PubMed ID: 36533359
[TBL] [Abstract][Full Text] [Related]
7. Hemophagocytic lymphohistiocytosis associated with ocrelizumab treatment in a patient with multiple sclerosis.
Machlańska A; Helbig G; Chromik K; Zapała M; Zwiernik B; Selmaj K
Mult Scler; 2021 Oct; 27(11):1803-1805. PubMed ID: 33666121
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and follow-up analysis of adult-onset Still's disease complicated by hemophagocytic lymphohistiocytosis.
Zhang Y; Yang Y; Bai Y; Yang D; Xiong Y; Zeng X
Clin Rheumatol; 2016 May; 35(5):1145-51. PubMed ID: 26809798
[TBL] [Abstract][Full Text] [Related]
9. Hemophagocytic lymphohistiocytosis: clinical analysis of 103 adult patients.
Li J; Wang Q; Zheng W; Ma J; Zhang W; Wang W; Tian X
Medicine (Baltimore); 2014 Mar; 93(2):100-105. PubMed ID: 24646466
[TBL] [Abstract][Full Text] [Related]
10. [Clinical analysis and follow-up study of Epstein-Barr virus associated-hemophagocytic lymphohistiocytosis in childhood].
Lu G; Xie ZD; Shen KL; Wu RH; Jin YK; Yang S; Liu CY
Zhonghua Er Ke Za Zhi; 2010 Feb; 48(2):121-6. PubMed ID: 20426937
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of five cases of hepatitis associated aplastic anemia presenting with hemophagocytic lymphohistiocytosis at onset].
Wei A; Ma HH; Zhang LP; Wu RH; Zhang R; Wang TY
Zhonghua Er Ke Za Zhi; 2020 Mar; 58(3):213-217. PubMed ID: 32135593
[No Abstract] [Full Text] [Related]
12. Hemophagocytic histiocytosis in severe SARS-CoV-2 infection: A bone marrow study.
Dandu H; Yadav G; Malhotra HS; Pandey S; Sachu R; Dubey K
Int J Lab Hematol; 2021 Dec; 43(6):1291-1301. PubMed ID: 34086418
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of 9 cases of drug induced hypersensitivity syndrome related hemophagocytic lymphohistiocytosis].
Zhao YZ; Ma HH; Wang D; Lian HY; Wang TY; Zhang R
Zhonghua Er Ke Za Zhi; 2024 Jan; 62(1):60-65. PubMed ID: 38154979
[No Abstract] [Full Text] [Related]
14. A Three-Step Screening Procedure for Early Identification of Children at High Risk of Hemophagocytic Lymphohistiocytosis.
Li X; Yan H; Xiao Z; Luo T; Xie L; Yang Y; Gong L; Tang Z; Tang M; Huang J; Zhang X; Zheng M; Yao Z; Zang P; Zhu D; Lu X
J Clin Immunol; 2023 Jul; 43(5):989-998. PubMed ID: 36877313
[TBL] [Abstract][Full Text] [Related]
15. An unusual cause of multiple organ dysfunction syndrome in the pediatric intensive care unit: hemophagocytic lymphohistiocytosis.
Karapinar B; Yilmaz D; Balkan C; Akin M; Ay Y; Kvakli K
Pediatr Crit Care Med; 2009 May; 10(3):285-90. PubMed ID: 19433941
[TBL] [Abstract][Full Text] [Related]
16. Reactive hemophagocytic syndrome in adult-onset Still disease: clinical features, predictive factors, and prognosis in 21 patients.
Bae CB; Jung JY; Kim HA; Suh CH
Medicine (Baltimore); 2015 Jan; 94(4):e451. PubMed ID: 25634183
[TBL] [Abstract][Full Text] [Related]
17. Hemophagocytic lymphohistiocytosis with advanced malignant melanoma accompanied by ipilimumab and nivolumab: A case report and literature review.
Mizuta H; Nakano E; Takahashi A; Koyama T; Namikawa K; Yamazaki N
Dermatol Ther; 2020 May; 33(3):e13321. PubMed ID: 32191382
[TBL] [Abstract][Full Text] [Related]
18. Pembrolizumab-induced Hemophagocytic Lymphohistiocytosis: an immunotherapeutic challenge.
Kalmuk J; Puchalla J; Feng G; Giri A; Kaczmar J
Cancers Head Neck; 2020; 5():3. PubMed ID: 32025343
[TBL] [Abstract][Full Text] [Related]
19. Haemophagocytic lymphohistiocytosis complicating pembrolizumab treatment for metastatic breast cancer in a patient with the
Al-Samkari H; Snyder GD; Nikiforow S; Tolaney SM; Freedman RA; Losman JA
J Med Genet; 2019 Jan; 56(1):39-42. PubMed ID: 30287596
[TBL] [Abstract][Full Text] [Related]
20. Two cases of lung cancer with hemophagocytic lymphohistiocytosis caused by immune checkpoint inhibitors.
Kurozumi A; Takahashi H; Watanabe T; Iwasaki Y
Thorac Cancer; 2021 May; 12(10):1625-1628. PubMed ID: 33783978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
